نتایج جستجو برای: fabry disease

تعداد نتایج: 1493456  

2008
Nassim Kamar Olivier Cointault Torsten Böhler Laure Esposito Lionel Rostaing

storage disorders such as Fabry disease, standardized screening for particular biomarkers is beginning to be considered a useful tool for diagnostics [6]. Future screening studies may help to identify Fabry patients that would gain immediate benefit from diagnosis. Screening for this disease is particularly timely in Canada, where a comparative clinical trial of currently approved ERT drugs is ...

Journal: :The Israel Medical Association journal : IMAJ 2012
Deborah Elstein Glen M Doniger Gheona Altarescu

BACKGROUND Recently, cognitive assessments of patients with Fabry disease highlighted neurocognitive impairment using test batteries that are time and labor intensive. OBJECTIVES To introduce a user-friendly self-administered tool for cognitive testing in patients with Fabry disease. METHODS We used a computerized system requiring about 1 hour for patient follow-up. All patients with enzyma...

Journal: :European clinical respiratory journal 2015
Camilla Kara Svensson Ulla Feldt-Rasmussen Vibeke Backer

BACKGROUND Fabry disease is an X-linked disorder caused by a deficiency of the lysosomal enzyme α-galactosidase A, resulting in accumulation of glycosphingolipids in multiple organs, primarily heart, kidneys, skin, CNS, and lungs. MATERIALS AND METHOD A systematic literature search was performed using the PubMed database, leading to a total number of 154 hits. Due to language restriction, thi...

2014
Silvia Pica Daniel M Sado Viviana Maestrini Marianna Fontana Steven K White Thomas Treibel Gabriella Captur Sarah Anderson Stefan K Piechnik Matthew D Robson Robin H Lachmann Elaine Murphy Atul Mehta Derralyn Hughes Peter Kellman Perry M Elliott Anna S Herrey James C Moon

BACKGROUND Cardiovascular magnetic resonance (CMR) derived native myocardial T1 is decreased in patients with Fabry disease even before left ventricular hypertrophy (LVH) occurs and may be the first non-invasive measure of myocyte sphingolipid storage. The relationship of native T1 lowering prior to hypertrophy and other candidate early phenotype markers are unknown. Furthermore, the reproducib...

Journal: :Pediatrics 2005
Markus Ries Surya Gupta David F Moore Vandana Sachdev Jane M Quirk Gary J Murray Douglas R Rosing Chevalia Robinson Ellen Schaefer Andreas Gal James M Dambrosia Scott C Garman Roscoe O Brady Raphael Schiffmann

BACKGROUND Fabry disease is an underdiagnosed, treatable, X-linked, multisystem disorder. OBJECTIVES To test the hypothesis that quality of life and sweating are decreased among pediatric patients with Fabry disease, compared with control subjects, and to provide quantitative natural history data and novel clinical end points for therapeutic trials. DESIGN Prospective, cross-sectional, obse...

Journal: :BMC Neurology 2002
David F Moore Gheona Altarescu Peter Herscovitch Raphael Schiffmann

BACKGROUND Fabry disease is a lysosomal X-linked enzyme deficiency of alpha-galactosidase A associated with an increased mortality and morbidity due to renal failure, cardiac disease and early onset stroke. METHODS We examined the functional blood flow response of the brain after visual stimulation (reversing checkerboard pattern), and cerebral vasoreactivity following acetazolamide (15 mg/kg...

Journal: :Human mutation 2008
Masaaki Shimotori Hiroki Maruyama Gen Nakamura Takayuki Suyama Fumiko Sakamoto Masaaki Itoh Shigeaki Miyabayashi Takahiro Ohnishi Norio Sakai Mari Wataya-Kaneda Mitsuru Kubota Toshiyuki Takahashi Tatsuhiko Mori Katsuhiko Tamura Shinji Kageyama Nobuo Shio Teruhiko Maeba Hirokazu Yahagi Motoko Tanaka Masayo Oka Hitoshi Sugiyama Toshiyuki Sugawara Noriko Mori Hiroko Tsukamoto Keiichi Tamagaki Shuuji Tanda Yuka Suzuki Chiya Shinonaga Jun-ichi Miyazaki Satoshi Ishii Fumitake Gejyo

Fabry disease is an X-linked recessive inborn metabolic disorder caused by a deficiency of the lysosomal enzyme alpha-galactosidase A (EC 3.2.1.22). The causative mutations are diverse, include both large rearrangements and single-base substitutions, and are dispersed throughout the 7 exons of the alpha-galactosidase A gene (GLA). Mutation hotspots for Fabry disease do not exist. We examined 62...

2016
Mustafa A Kamani Philippe Provençal Michel Boutin Natalia Pacienza Xin Fan Anton Novak Tonny C Huang Beth Binnington Bryan C Au Christiane Auray-Blais Clifford A Lingwood Jeffrey A Medin

AIM Fabry disease is caused by α-galactosidase A deficiency leading to accumulation of globotriaosylceramide (Gb3) in tissues. Clinical manifestations do not appear to correlate with total Gb3 levels. Studies examining tissue distribution of specific acyl chain species of Gb3 and upstream glycosphingolipids are lacking. MATERIAL & METHODS/RESULTS Thorough characterization of the Fabry mouse s...

Journal: :Cases Journal 2008
Massimiliano Sorbello Massimiliano Veroux Melania Cutuli Gianluigi Morello Annalaura Paratore Mirko Tindaro Sidoti Jessica Giuseppina Maugeri Massimiliano Gagliano Giuseppe Giuffrida Daniela Corona Pierfrancesco Veroux

Fabry's Disease is a rare genetic syndrome, with a classic X-linked alpha -galactosidase A deficiency phenotype, responsible for glico-sphyngolypids metabolism impairment with clinical effects in several organs and functions. We describe the anaesthesiologic implications of two patients with Fabry disease who underwent a kidney transplantation from a deceased donor. We recommend careful preoper...

2011
U. Feldt-Rasmussen

Fabry disease, an X-linked lysosomal storage disorder, results from deficient activity of the enzyme α-galactosidase A. Affected males with the classic phoenotype have acroparaesthesias, hypohidrosis, and corneal opacities in childhood and develop renal failure, cardiac hypertrophy or strokes in the third to fifth decade of life. Some female heterozygotes are asymptomatic, some as severely affe...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید